Power Stop B1087 Rear Autospecialty Brake Shoes Excellence $21 Power Stop B1087 Rear Autospecialty Brake Shoes Automotive Replacement Parts Brake System Power Stop B1087 Rear Autospecialty Brake Shoes Excellence Automotive , Replacement Parts , Brake System,Autospecialty,$21,Rear,www.cozzigiulioauto.com,B1087,Stop,Shoes,/Fusulina1553383.html,Power,Brake Automotive , Replacement Parts , Brake System,Autospecialty,$21,Rear,www.cozzigiulioauto.com,B1087,Stop,Shoes,/Fusulina1553383.html,Power,Brake $21 Power Stop B1087 Rear Autospecialty Brake Shoes Automotive Replacement Parts Brake System

Power Popular standard Stop B1087 Rear Autospecialty Brake Shoes Excellence

Power Stop B1087 Rear Autospecialty Brake Shoes

$21

Power Stop B1087 Rear Autospecialty Brake Shoes

|||

Product description

Autospecialty brake shoes are engineered to satisfy the most demanding professional installers. The semi-metallic brake shoes are post cured for more brake power and shorter break-in time. The shoes are precision arc ground for proper fitment to the drum. All shoes are 100% asbestos free. Our shoes feature chamfers to assure noise free braking, without chatter. Made from 100% new Steel that is black coated to resist rust.


From the manufacturer

Power Stop B1087 Rear Autospecialty Brake Shoes

Editor's Picks

COVID-19 in Quebec

STAY CONNECTED

MONTREAL ELECTION

Highlights from Across Canada

CTVNews.ca Top Stories

Queen Elizabeth II, 95, is advised to rest for 2 weeks

Queen Elizabeth II has been advised to rest for at least the next two weeks, accepting doctors' recommendations to take on only light duties and not travel, Buckingham Palace said Friday. The decision comes days after the 95-year-old sovereign underwent medical tests and spent the night at London's King Edward VII's Hospital, her first such stay in in eight years.

NACI names several more groups who should qualify for COVID-19 booster shots

The National Advisory Committee on Immunization has expanded eligibility guidelines for booster shots of COVID-19 vaccines. The committee now recommends mRNA boosters to people who received two doses of the Oxford-AstraZeneca vaccine, adults over the age of 70, front-line health-care workers with a short interval between their first two doses, and people from First Nations, Inuit and Metis communities.

LISTEN LIVE